(a) An individual or entity required to register under this part must maintain complete records relating to the activities covered by this part. Such records must include:
(1) An accurate, current inventory for each select agent (including viral genetic elements, recombinant and/or synthetic nucleic acids, and organisms containing recombinant and/or synthetic nucleic acids) held in long-term storage (placement in a system designed to ensure viability for future use, such as in a freezer or lyophilized materials), including:
(i) The name and characteristics (e.g., strain designation, GenBank Accession number, etc.),
(ii) The quantity acquired from another individual or entity (e.g., containers, vials, tubes, etc.), date of acquisition, and the source,
(iii) Where stored (e.g., building, room, and freezer),
(iv) When moved from storage and by whom and when returned to storage and by whom,
(v) The select agent used and purpose of use,
(vi) Records created under Sec. 73.16 and 9 CFR 121.16 (Transfers),
(vii) For intra-entity transfers (sender and the recipient are covered by the same certificate of registration), the select agent, the quantity transferred, the date of transfer, the sender, and the recipient, and
(viii) Records created under Sec. 73.19 and 9 CFR part 121.19 (Notification of theft, loss, or release),
(2) An accurate, current accounting of any animals or plants intentionally or accidentally exposed to or infected with a select agent (including number and species, location, and appropriate disposition);
(3) Accurate, current inventory for each toxin held, including:
(i) The name and characteristics,
(ii) The quantity acquired from another individual or entity (e.g., containers, vials, tubes, etc.), date of acquisition, and the source,
(iii) The initial and current quantity amount (e.g., milligrams, milliliters, grams, etc.),
(iv) The toxin used and purpose of use, quantity, date(s) of the use and by whom,
(v) Where stored (e.g., building, room, and freezer),
(vi) When moved from storage and by whom and when returned to storage and by whom including quantity amount,
(vii) Records created under Sec. 73.16 and 9 CFR part 121.16 (Transfers),
(viii) For intra-entity transfers (sender and the recipient are covered by the same certificate of registration), the toxin, the quantity transferred, the date of transfer, the sender, and the recipient,
(ix) Records created under Sec. 73.19 and 9 CFR part 121.19 (Notification of theft, loss, or release), and
(x) If destroyed, the quantity of toxin destroyed, the date of such action, and by whom,
(4) A current list of all individuals that have been granted access approval from the HHS Secretary or Administrator,
(5) Information about all entries into areas containing select agents or toxins, including the name of the individual, name of the escort (if applicable), and date and time of entry,
(6) Accurate, current records created under Sec. 73.9 and 9 CFR part 121.9 (Responsible Official), Sec. 73.11 and 9 CFR part 121.11 (Security), Sec. 73.12 and 9 CFR part 121.12 (Biosafety), Sec. 73.14 and 9 CFR part 121. 14 (Incident response), and Sec. 73.15 and 9 CFR part 121.15 (Training), and
(7) A written explanation of any discrepancies.
(b) The individual or entity must implement a system to ensure that all records and data bases created under this part are accurate, have controlled access, and that their authenticity may be verified.
(c) All records created under this part must be maintained for three years and promptly produced upon request. [70 FR 13316, Mar. 18, 2005, as amended at 77 FR 61115, Oct. 5, 2012]